OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy
Pietro Ripani, Matteo Mucci, Stefano Pantano, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Pietro Ripani, Matteo Mucci, Stefano Pantano, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Showing 7 citing articles:
Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS)
Dinu Zinovie Ciobanu, Nara Liessi, Valeria Tomati, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 6, pp. 1167-1172
Open Access | Times Cited: 3
Dinu Zinovie Ciobanu, Nara Liessi, Valeria Tomati, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 6, pp. 1167-1172
Open Access | Times Cited: 3
Elexacaftor/tezacaftor/ivacaftor induced liver enzymes abnormalities in breastfed infants: a series of 3 cases*
Sandrine Bergeron, Camille Audousset, Gurvan Bourdon, et al.
Therapies (2024)
Closed Access | Times Cited: 1
Sandrine Bergeron, Camille Audousset, Gurvan Bourdon, et al.
Therapies (2024)
Closed Access | Times Cited: 1
Advances in Research on Aging in Female Infertility and Pathologic Pregnancy
Bin Liu, Gendie E. Lash, Fengxiang Wei, et al.
Frontiers research topics (2024)
Open Access
Bin Liu, Gendie E. Lash, Fengxiang Wei, et al.
Frontiers research topics (2024)
Open Access
Use of CFTR modulators in pregnancy: new information for neonatal, paediatrics and midwifery teams
Haji Sheeraz Khan, Paula Tran
Archives of Disease in Childhood Fetal & Neonatal (2024), pp. fetalneonatal-327678
Closed Access
Haji Sheeraz Khan, Paula Tran
Archives of Disease in Childhood Fetal & Neonatal (2024), pp. fetalneonatal-327678
Closed Access
Therapeutic drug monitoring of elexacaftor, tezacaftor, and ivacaftor before, during, and after pregnancy in women with cystic fibrosis: an observational study
Shintia Christina, Michael Paal, Katharina Habler, et al.
Respiratory Medicine (2024) Vol. 236, pp. 107868-107868
Closed Access
Shintia Christina, Michael Paal, Katharina Habler, et al.
Respiratory Medicine (2024) Vol. 236, pp. 107868-107868
Closed Access
Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis
Adam Metcalf, Stacey L. Martiniano, Scott D. Sagel, et al.
Journal of Cystic Fibrosis (2024)
Closed Access
Adam Metcalf, Stacey L. Martiniano, Scott D. Sagel, et al.
Journal of Cystic Fibrosis (2024)
Closed Access
Pregnancy in People With Cystic Fibrosis Treated With Highly Effective Modulator Therapy
Jennifer L. Goralski, Asha N. Talati, Emily E. Hardisty, et al.
Obstetrics and Gynecology (2024) Vol. 145, Iss. 1, pp. 47-54
Open Access
Jennifer L. Goralski, Asha N. Talati, Emily E. Hardisty, et al.
Obstetrics and Gynecology (2024) Vol. 145, Iss. 1, pp. 47-54
Open Access
